Evidence map›Paper›PMID 40167778›Full record

ArticleWorld journal of urology2025

Will artificial intelligence (AI) replace cytopathologists: a scoping review of current applications and evidence of A.I. in urine cytology.

Jingqiu Li, Tsung Wen Chong, Khi Yung Fong, Benjamin Lim Jia Han, Si Ying Tan, Joanne Tan San Mui, Li Yan Khor, Bhaskar Kumar Somoni, Thomas R W Herrmann, Vineet Gauhar and 3 more

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. The future of endourology is now.World journal of urology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jingqiu LiDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Tsung Wen ChongDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Khi Yung FongMinistry of Health Holdings, Singapore, Singapore.
Benjamin Lim Jia HanMinistry of Health Holdings, Singapore, Singapore.
Si Ying TanDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Joanne Tan San MuiDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Li Yan KhorDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Bhaskar Kumar SomoniUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Thomas R W HerrmannDepartment of Urology, Kantonspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
Vineet GauharDepartment of Urology, Ng Teng Fong General Hospital, Singapore, Singapore.
Valerie Gan Huei LiDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Christopher Cheng Wai SamDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Ee Jean LimDepartment of Urology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore. eejeanlim@gmail.com.ORCID http://orcid.org/0000-0002-5242-0651

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUrine cytology, while valuable in facilitating the detection and surveillance of bladder cancer, has notable limitations. The application of artificial intelligence (AI) in urine cytology holds significant promise for improving diagnostic accuracy and efficiency. Our scoping review aims to assess the current evidence of AI's utility in urine cytology.

methodAn electronic literature research on the application of AI in the setting of urine cytology was conducted on PubMed, EMBASE, and Scopus from inception to 1st November 2024. Case reports, abstracts, and reviews were excluded from this analysis. Our search strategy retrieved 1356 articles; after excluding 142 duplicates, the remaining 1214 papers were screened by title and abstract. 31 studies entered full-article review, and a total of 16 articles were included in the final analysis.

resultsThe main application of AI in urine cytology diagnosis is to automate the identification and characterization of abnormal cells. It has also been utilized for risk stratification of abnormal cells, predicting histologic results from urine cytology samples, and predicting bladder cancer recurrence. Current limitation includes the need for robust training datasets and validation studies to ensure the generalizability of AI algorithms.

conclusionIn summary, AI in urine cytology, though still developing, shows significant promise in enhancing diagnostic accuracy and efficiency. Current evidence suggests that AI, as a valuable tool, could revolutionize urinary tract cancer diagnosis and management.

Indexed as

Artificial IntelligenceCytodiagnosisUrinary Bladder NeoplasmsUrineHumansUrinalysisArtificial intelligenceUrine cytology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.